BR100 Increased By (0.99%)
BR30 Increased By (0.38%)
KSE100 Increased By (1.06%)
KSE30 Increased By (1.14%)
BECO 5.39 Increased By ▲ 0.07 (1.32%)
BML 56.48 Increased By ▲ 1.39 (2.52%)
BOP 35.09 Increased By ▲ 0.05 (0.14%)
CNERGY 8.17 Increased By ▲ 0.08 (0.99%)
DCL 11.44 Increased By ▲ 0.08 (0.7%)
FCCL 57.55 Increased By ▲ 1.36 (2.42%)
FCSC 5.00 Decreased By ▼ -0.01 (-0.2%)
FFL 17.88 Increased By ▲ 0.20 (1.13%)
FNEL 1.25 Increased By ▲ 0.01 (0.81%)
HUMNL 11.17 Increased By ▲ 0.24 (2.2%)
KEL 8.54 Decreased By ▼ -0.03 (-0.35%)
KOSM 6.73 Increased By ▲ 0.24 (3.7%)
MLCF 106.91 Increased By ▲ 0.40 (0.38%)
NBP 198.50 Decreased By ▼ -1.26 (-0.63%)
PACE 11.07 Increased By ▲ 0.05 (0.45%)
PAEL 45.45 Increased By ▲ 0.45 (1%)
PIAHCLA 31.43 Increased By ▲ 2.86 (10.01%)
PIBTL 19.08 Increased By ▲ 0.81 (4.43%)
PPL 242.62 Decreased By ▼ -1.87 (-0.76%)
PRL 35.67 Increased By ▲ 0.73 (2.09%)
PTC 65.52 Decreased By ▼ -0.30 (-0.46%)
SEARL 94.54 Increased By ▲ 0.49 (0.52%)
SSGC 32.08 Increased By ▲ 1.25 (4.05%)
TELE 8.87 Increased By ▲ 0.17 (1.95%)
THCCL 65.66 Increased By ▲ 0.67 (1.03%)
TPLP 10.73 Increased By ▲ 0.47 (4.58%)
TREET 25.11 Increased By ▲ 0.24 (0.97%)
TRG 63.67 Increased By ▲ 0.31 (0.49%)
WAVES 10.70 Increased By ▲ 0.05 (0.47%)
WTL 1.25 Increased By ▲ 0.01 (0.81%)
By

LONDON: London stocks closed sharply lower on Monday, weighed by travel and energy stocks, while a resurgence in novel coronavirus cases stoked fears of a faltering economic recovery and dragged down European markets.

After rising nearly 0.1% in morning trade, the blue-chip FTSE 100 index fell 1.2%, led by declines in travel and leisure, personal goods makers, retailers and aero stocks.

Energy and mining weighed the most on the index due to weaker commodity prices.

The domestically focussed mid-cap FTSE 250 index lost 1.4% even as European Union chief negotiator Michel Barnier and his team extended their London visit until Wednesday to try and clinch a Brexit trade deal.

After a stimulus-backed rally from pandemic lows, the FTSE 100 has been trading in tight ranges since June due to Brexit-related uncertainty and concerns over coronavirus curbs.

In a bright spot, AstraZeneca Plc rose 1.7% after the drugmaker resumed the US trial of its experimental Covid-19 vaccine that is being developed with the University of Oxford, and said it produced a similar immune response in both older and younger adults.

The wider healthcare index added 1%.

Educational publisher Pearson Plc added 3% after UBS upgraded the stock to a "buy" rating. Coca-Cola European Partners (CCEP) rose 0.3% after the soft drink bottler made a buyout offer of $6.6 billion for its Australian peer Coca-Cola Amatil Ltd.

Comments

Comments are closed for this article.